Viewing Study NCT00504192


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-01-03 @ 9:33 AM
Study NCT ID: NCT00504192
Status: COMPLETED
Last Update Posted: 2014-05-20
First Post: 2007-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor: Soonchunhyang University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module